HKU Scholars Hub: Browsing DSpace

Browsing by Author rp01917

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 20 of 78 next >

Title	Author(s)	Issue Date
A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients Journal:Investigational New Drugs	Yau, TCC Cheng, PNM Chiu, WYJ Kwok, GW Leung, RCY Liu, AM Cheung, TT Ng, CT	2021
A phase 1b trial of AMG386 and temsirolimus in patients with advanced solid tumor Proceeding/Conference:26th EORTC-NCI-AACR Symposium	Chiu, WYJ Hotte, SJ Kollmannsberger, CK Renouf, DJ Cescon, DW Hedley, D Chow, S Moscow, J Perry, M Diaz-Padilla, I Tan, D Hirte, H McWhirter, E Chen, H Siu, LL Bedard, PL	2014
A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041) Journal:Investigational New Drugs	Chiu, WYJ Hotte, SJ Kollmannsberger, CK Renouf, DJ Cescon, DW Hedley, D Chow, S Moscow, J Perry, M Diaz-Padilla, I Tan, D Hirte, H McWhirter, E Chen, H Siu, LL Bedard, PL	2016
A Phase I, Single- and Multiple-dose Study to Evaluate the Pharmacokinetics of Elbasvir and Grazoprevir in Healthy Chinese Participants Journal:Clinical Therapeutics	Cheung, TT Chiu, WYJ Yuen, RMF Lam, KSL Cheung, BMY Feng, HP Yeh, WW Wang, J Li, W Zhao, XM Wang, Z Mu, S	2018
A phase II study of neoadjuvant chemotherapy using combined taxane, anthracycline, and cyclophosphamide in high risk HER2-negative locally advanced breast cancer Proceeding/Conference:GBCC / IBCS 2015	Chiu, WYJ Leung, RCY Suen, TKD Chen, THC Chow, CYL Kwok, G Wong, H Cheung, P Yau, TCC Kwong, A	2015
A pilot study of molecular-guided neoadjuvant chemotherapy in patients with triple negative breast cancer Proceeding/Conference:Global Breast Cancer Conference (GBCC), 2017	Chiu, WYJ Leung, RCY Shin, VY Cheuk, WY Au, CH Wong, L Chan, TL Lo, J Ma, E Kwong, A	2017
A pre-menopausal lady with high risk breast cancer requiring ovarian suppression as adjuvant therapy Proceeding/Conference:Endocrine, Diabetes & Metabolism Hong Kong (EDM) 3rd Annual Meeting	Chiu, WYJ	2020
Advanced Pancreatic Cancer: Flourishing Novel Approaches in the Era of Biological Therapy Journal:Oncologist	Chiu, JWY Wong, HYH Leung, RCY Pang, RWC Cheung, TT Fan, ST Poon, RTP Yau, TCC	2014
Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapy Journal:Anti-Cancer Agents in Medicinal Chemistry	Leung, R Lang, B Wong, H Chiu, J Wan, KY Shek, T Woo, YC Lo, CY Yau, T	2012
Biomarker analyses of Asian women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC) receiving ribociclib (RIB) + endocrine therapy (ET) Proceeding/Conference:ESMO (European Society for Medical On) ASIA 2018	Yap, YS Masuda, N Ito, Y Ishikawa, T Kim, SJ Aruga, T Toyama, T Saeki, T Yamanaka, T Saito, M Watanabe, J Takahashi, M Nakamura, S Inoue, K Suarez-Vizcarra, J He, W Solovieff, N Su, F Chiu, WYJ	2018
BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy Journal:Cancer Research and Treatment	Kim, SB Do, IG Tsang, J Kim, TY Yap, YS Cornelia, G Gong, G Paik, S Lee, S Ng, TY Park, S Oh, HS Chiu, J Sohn, J Lee, M Choi, YJ Lee, EM Park, KH Nathaniel, C Ro, J	2019
CDK4/6 inhibitor -- Asian data and real life experience Proceeding/Conference:Chinese Society of Clinical Oncology (CSCO) Annual Meeting, 2016	Chiu, WYJ	2016
Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapy Journal:Postgraduate Medical Journal	Chiu, JW Leung, R Tang, V Cheuk, WY Lo, J Kwok, GW Wong, H Suen, D Cheung, P Wong, TT Yau, T Kwong, A	2019
Clinical strategy to over Trastuzumab resistance Proceeding/Conference:Philippine Society of Medical Oncology Meeting	Chiu, WYJ	2016
Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer Journal:Medical Oncology	Wong, H Lau, S Leung, R Chiu, J Cheung, P Wong, TT Liang, R Epstein, RJ Yau, T	2012
Complications of traditional Chinese/herbal medicines (TCM)-a guide for perplexed oncologists and other cancer caregivers Journal:Supportive Care in Cancer	Chiu, J Yau, T Epstein, RJ	2009
Early clinical trials on Asia Proceeding/Conference:3rd International Conference on Phase 1 and Early Phase Clinical Trials, ICPOEP 2016	Chiu, WYJ	2016
Editorial to “Palbociclib and letrozole in advanced breast cancer” Journal:Translational Cancer Research	Chiu, WYJ Kwok, G Yau, TCC Leung, R	2017
Efficacy and safety analysis of Chinese patients in monarchE: abemaciclib combined with adjuvant endocrine therapy for high-risk HR+, HER2− early breast cancer Proceeding/Conference:Journal of Clinical Oncology	Shao, Z Zhang, Q Song, C Ouyang, Q Liu, Z Liu, Q Feng, J Chiu, WYJ Tseng, LM Qian, C	2021
Efficacy and tolerability of adjuvant oral capecitabine plus intravenous oxaliplatin (XELOX) in Asian patients with colorectal cancer: 4-year analysis Journal:Asian Pacific Journal of Cancer Prevention	Chiu, Joanne Tang, Vikki Leung, Roland Wong, Hilda Chu, Kinwah Poon, Jensen Epstein, Richard John Yau, Thomas	2013

Showing results 1 to 20 of 78 next >